4.72
前日終値:
$4.79
開ける:
$4.91
24時間の取引高:
663.38K
Relative Volume:
1.16
時価総額:
$156.69M
収益:
-
当期純損益:
$-86.60M
株価収益率:
-1.6664
EPS:
-2.8324
ネットキャッシュフロー:
$-67.37M
1週間 パフォーマンス:
+4.19%
1か月 パフォーマンス:
+14.56%
6か月 パフォーマンス:
+4.89%
1年 パフォーマンス:
-60.99%
Lexeo Therapeutics Inc Stock (LXEO) Company Profile
名前
Lexeo Therapeutics Inc
セクター
電話
(212) 547-9879
住所
345 PARK AVENUE SOUTH, NEW YORK
LXEO を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
LXEO
Lexeo Therapeutics Inc
|
4.72 | 258.57M | 0 | -86.60M | -67.37M | -2.8324 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | -614.78M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Lexeo Therapeutics Inc Stock (LXEO) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-07-31 | 開始されました | Oppenheimer | Outperform |
2024-06-13 | 開始されました | Robert W. Baird | Outperform |
2024-06-06 | 開始されました | H.C. Wainwright | Buy |
2023-11-28 | 開始されました | Chardan Capital Markets | Buy |
2023-11-28 | 開始されました | JP Morgan | Overweight |
2023-11-28 | 開始されました | Leerink Partners | Outperform |
2023-11-28 | 開始されました | RBC Capital Mkts | Outperform |
2023-11-28 | 開始されました | Stifel | Buy |
すべてを表示
Lexeo Therapeutics Inc (LXEO) 最新ニュース
Lexeo Therapeutics price target lowered to $15 from $20 at Chardan - TipRanks
Chart Analysts Warn of Resistance Near Lexeo Therapeutics Inc. PriceEntry Point & Free Accurate Trade Setup Notifications - sundaytimes.kr
Lexeo Therapeutics, Inc.: Promising Gene Therapy Advancements and Strategic Positioning in Cardiac Treatments - TipRanks
Lexeo Therapeutics stock price target lowered to $9 at H.C. Wainwright - Investing.com
Lexeo Therapeutics Reports Q2 2025 Financial Results - TipRanks
Lexeo Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Lexeo Reports Q2 Loss as Costs Jump 129% - sharewise.com
Lexeo Therapeutics: Can a Deep Pipeline and Regulatory Momentum Offset Earnings Woes? - AInvest
Lexeo Therapeutics Appoints New Chief Financial Officer - TipRanks
Lexeo Therapeutics appoints Louis Tamayo as CFO - MarketScreener
Lexeo Therapeutics, Inc. SEC 10-Q Report - TradingView
Lexeo Therapeutics Reports Second Quarter 2025 Financial Results and Operational Highlights - Yahoo Finance
What makes Lexeo Therapeutics Inc. stock price move sharplyLow Float Short Squeeze Picks - thegnnews.com
Lexeo Therapeutics Inc. Matches Institutional Buying FilterBuy Low Sell High Stock Watch Strategy in Focus - beatles.ru
Stifel Maintains Buy Rating on Lexeo Therapeutics (LXEO) - MSN
Lexeo Therapeutics Inc. Stock Approaches Key Moving AverageChart Breakout Buy Signal Detection Confirmed - beatles.ru
Traders Watching For Reversal Pattern in Lexeo Therapeutics Inc.Reliable Alerts for Daily Stock Movers Released - metal.it
Oppenheimer Begins Coverage on Lexeo Therapeutics (NASDAQ:LXEO) - MarketBeat
How does Lexeo Therapeutics Inc. generate profit in a changing economyBuild wealth with reliable stock picks - Jammu Links News
How strong is Lexeo Therapeutics Inc. company’s balance sheetGet real-time updates on market trends - Jammu Links News
What is Lexeo Therapeutics Inc. company’s growth strategyFree Risk Assessment Services - Jammu Links News
Is it the right time to buy Lexeo Therapeutics Inc. stockAchieve consistent profits with expert advice - Jammu Links News
How many analysts rate Lexeo Therapeutics Inc. as a “Buy”Superior returns - Jammu Links News
Published on: 2025-08-04 05:32:29 - Jammu Links News
What are the technical indicators suggesting about Lexeo Therapeutics Inc.Consistent double returns - Jammu Links News
What are Lexeo Therapeutics Inc. company’s key revenue driversPhenomenal returns - Jammu Links News
How does Lexeo Therapeutics Inc. compare to its industry peersMaximize your gains with professional insights - Jammu Links News
What is the risk reward ratio of investing in Lexeo Therapeutics Inc. stockMaximize gains with professional stock picks - Jammu Links News
Is Lexeo Therapeutics Inc. a good long term investmentMarket-beating performance - Jammu Links News
What are analysts’ price targets for Lexeo Therapeutics Inc. in the next 12 monthsBuild a portfolio with strong long-term growth - Jammu Links News
Published on: 2025-08-03 06:15:28 - Jammu Links News
What is the dividend policy of Lexeo Therapeutics Inc. stockDynamic profit opportunities - Jammu Links News
How volatile is Lexeo Therapeutics Inc. stock compared to the marketDiscover market opportunities with real-time data - Jammu Links News
Lexeo Therapeutics Analyst Begins Coverage on Bullish Note; Top 3 Initiations for Thursday - AInvest
This Lexeo Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday - Benzinga
Oppenheimer Initiates Lexeo Therapeutics(LXEO.US) With Buy Rating, Announces Target Price $20 - 富途牛牛
Lexeo Therapeutics Initiates Coverage: Oppenheimer Outperform Rating with $20 PT - AInvest
Lexeo Therapeutics shares rise 7.31% premarket after FDA grants breakthrough therapy designation to LX2006. - AInvest
Oppenheimer initiates Lexeo Therapeutics stock with Outperform rating By Investing.com - Investing.com India
Oppenheimer initiates Lexeo Therapeutics stock with Outperform rating - Investing.com Australia
Should I hold or sell Lexeo Therapeutics Inc. stock in 2025Advanced Screener Ideas For Fast Growth - Jammu Links News
Stifel Reiterates Buy Rating for Lexeo Therapeutics with $21 Price Target Following FDA Breakthrough Therapy Designation for LX2006 - AInvest
Candlestick Reversal Detected on Lexeo Therapeutics Inc.’s ChartPotential Breakout Stock List Published This Week - metal.it
Lexeo Therapeutics' LX2006 Receives Breakthrough Therapy Designation from FDA, Shares Rise 17% - AInvest
Lexeo Therapeutics Inc. Earnings Report Breakdown: What Investors Should KnowGrowth Based Stock Signal Screener Updated - metal.it
11 Best New Penny Stocks to Buy Right Now - Insider Monkey
What does LXEO's flat EPS in 2024 suggest for investors? - AInvest
How did LXEO's operating expenses trend in Q4 2024? - AInvest
Lexeo Therapeutics Inc (LXEO) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):